Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

2023 Patient Perspective - Clinical Trials Experiences Through Storytelling
dbrock
Applications are now open for the 2023 Patient Perspectives Program - Clinical Trials Experiences Through Storytelling
Author
Denise Brock
Image
Patient Perspectives Clinical Trials
We are excited to launch our second year of this program - Patient Perspectives - Clinical Trials Experiences Through Storytelling

GRACE’s mission is to provide expert-mediated information directly to cancer patients and their caregivers to empower them to become direct partners in their cancer treatment.  The Clinical Trials Experiences Through Storytelling program helps patients to become educators and to help others learn about the journey they may be beginning or continuing on.  To apply online please click here.

 

GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview

The goal of this Patient Perspectives program is to give a voice to those who have experience in participating in a clinical trial for a cancer diagnosis.  By telling your story, you can educate others on the process, discuss your difficulties and share your accomplishments.  Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  This is a paid opportunity and you will receive a stipend for your participation!
 

Storytelling will take the form of written, video and/or audio/podcast to reach the largest audience.  GRACE staff will coach and support participants on digital outreach and advocacy. 

 

All people currently enrolled in, or with past enrollment in, a clinical trial for a cancer diagnosis are welcome and encouraged to apply. GRACE’s designated committee will review the nominees and select up to 3 applicants for participation in the 2023-24 program.

 

Who is GRACE?

The Global Resource for Advancing Cancer Education (GRACE, cancerGRACE.org) is a non-profit organization founded by leading Thoracic Oncologist, Dr. Howard (Jack) West, in 2007.  GRACE’s mission is to provide expert-mediated information directly to people with a cancer diagnosis and their caregivers to empower them to become direct partners in their cancer treatment.  We currently produce over 300 short videos each year, reaching our community in over 190 countries. 

 

Benefits of Participation

Applicants selected for this year’s program will work closely with GRACE staff to develop new educational content and learn new communication skills through the storytelling process.
Participants will receive training on digitally distributed content, social media and other platforms.  Participants work will be highlighted and shared by GRACE, our network of established leaders in the oncology community, and GRACE board members with an array of interests and connections.    

Participants will receive a stipend, training in communication and media platforms, and a tech ‘package’.  

 

Expectations

Participants will work with GRACE to develop program formats and production and will present a proposal based on their experience in a clinical trial program.  Participants will be expected to attend (via ZOOM) regular monthly meetings through the program year to learn and to discuss their ideas. A minimum of three (3) media productions per participant will be expected by the end of the program.  

 

Ideal Candidates

 

People who are navigating a cancer diagnosis, who are currently or have been involved in a clinical trial, and who have a passion for helping others and telling their story are ideal for this program.  

 

Applicants should have a particular interest and passion for communications, sharing experiences, storytelling, and patient education.  People looking for a way to give back to the cancer community, who exhibit strong written and oral communication skills coupled with a passion for sharing experiences in order to educate and advocate will thrive in this program.   GRACE will guide them through boosting their voice to advocate for themselves and others in the cancer community.     

 

2023 is our third year for this program, and we are excited to continue to generate a platform for patient advocacy and sharing patient education in the area of clinical trials.  

All application forms must be submitted by July 1, 2023 for consideration. Applicants will be contacted by August 1, 2023, with information regarding acceptance and the next steps.

To apply online please click here OR download the above attached pdf form and email it to dbrock@cancerGRACE.org.

Any questions, please contact  dbrock@cancergrace.org or 888-501-1025 x2.
 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on